Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vixotrigine in Neuropathic Pain From Lumbosacral Radiculopathy
NCT02935608Phase 2Completed
- Sponsor
- Biogen
- Start
- Oct 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of vixotrigine in lumbosacral radiculopathy, sponsored by Biogen. Started Oct 2016; status: completed.
02
Drugs
vixotrigine
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on NCT02935608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02935608.